Table 1.
Post-translational modifications of biopharmaceuticals expressed in the secretory system of microalgae.
Expressed protein | Promoter | N-glycosylation sitea | Glycosylationb | References |
---|---|---|---|---|
IN C. REINHARDTII | ||||
Human EPO | Hsp70A/RbcS2 | Yes | Yes | Eichler-Stahlberg et al., 2009 |
IN P. TRICORNUTUM | ||||
Monoclonal human IgG against the Hepatitis B surface antigen | Nitrate reductase | Yes | Yes | Hempel et al., 2011b; Hempel and Maier, 2012 |
Hepatitis B surface antigen | Nitrate reductase | Yes | No | Hempel et al., 2011b |
IN D. SALINA | ||||
Hepatitis B surface antigen | Maize Ubiquitin + Ω TMV enhancer | Yes | No | Geng et al., 2003 |
Predicted N-glycosylation sites by bio-informatic analysis of the protein sequence.
Experimental evidence of the presence of N-glycans attached to the N-glycosylation site.